Joshua D. Schiffman - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Joshua D. Schiffman's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Joshua D. Schiffman
Verified
Associate Editor, JCO- Precision Oncology
Beats
all other software segments
Content
Disparities in childhood leukemia survival for Asian, Native Hawaiian, and Pacific Islanders in the United States
By Mia Hashibe, Kimberly Herget, Joshua D. Schiffman, Vivian Chang| Wiley Online Library Verified 1 INTRODUCTION Incidence rates of acute myeloid leukemia (AML) in the Asian, Native Hawaiian, and Pacific Islander (ANHPI) population may be increasing statistically significantly in contrast to acute lymphoid leukemia (ALL) rates, which did not show changes over the 2000–2019 period.1 Upon disaggregation of the ANHPI population, incidence rate ratios showed no differences for East Asian, Filipino, and Asian Indian and Pakistani populations for childhood leukemia when compared to the...
By Rachael Natrajan, Lisa M. Abegglen, Joshua D. Schiffman, Marcela Braga Mansur| Nature Verified AbstractThe emergence of drug-resistant cells, most of which have a mutated TP53 gene, prevents curative treatment in most advanced and common metastatic cancers of adults. Yet, a few, rarer malignancies, all of which are TP53 wild type, have high cure rates. In this Perspective, we discuss how common features of curable cancers offer insights into the evolutionary and developmental determinants of drug resistance. Acquired loss of TP53 protein function is the most common genetic change in cancer.
Disparities in childhood leukemia survival for Asian, Native Hawaiian, and Pacific Islanders in the United States
By Mia Hashibe, Kimberly Herget, Joshua D. Schiffman, Vivian Chang| Wiley Online Library Verified 1 INTRODUCTION Incidence rates of acute myeloid leukemia (AML) in the Asian, Native Hawaiian, and Pacific Islander (ANHPI) population may be increasing statistically significantly in contrast to acute lymphoid leukemia (ALL) rates, which did not show changes over the 2000–2019 period.1 Upon disaggregation of the ANHPI population, incidence rate ratios showed no differences for East Asian, Filipino, and Asian Indian and Pakistani populations for childhood leukemia when compared to the...
Company Info
JCO- Precision Oncology
Salt Lake City, Utah, United States
+1 801-213-2562